PHS 2015 02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR R43/R44) | Apply Online

Opportunity Summary:

The opportunity titled "PHS 2015-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR R43/R44)" (Funding Opportunity Number PA-15-269) is a federal discretionary grant program designed to help US small business concerns develop and commercialize innovative research and development products that align with public health and human services missions. It is an omnibus, or "parent," SBIR solicitation, meaning it provides a broad entry point for small businesses to propose R and D projects across a wide range of topics supported by multiple federal health-related agencies and components, rather than being restricted to a single narrowly defined research initiative.

At its core, the announcement invites eligible US small businesses with the technical expertise and research capabilities to contribute to the missions of the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and the Administration for Children and Families (ACF). Applicants are expected to propose projects that fit within the research topic areas identified by the participating awarding components under the PHS 2015-02 SBIR/STTR Program Descriptions and Research Topics. In practical terms, this means companies can bring forward innovations such as new diagnostics, therapeutics, medical devices, digital health tools, public health technologies, behavioral interventions, research tools, or service delivery approaches, as long as they align with the topic areas and the mission needs of the participating agencies.

The funding instrument is a grant under the SBIR mechanism, specifically the R43 (generally associated with Phase I feasibility work) and R44 (generally associated with Phase II full research and development). While the detailed structure of Phase I versus Phase II is defined in the full FOA and SBIR policy, the intent of the R43/R44 pathway is typically to support a progression from early proof-of-concept and feasibility testing to more advanced development, validation, and readiness steps that position an innovation for commercialization and real-world adoption. The program is explicitly focused on small business-led innovation, so the small business is the applicant organization and the primary driver of the proposed R and D effort.

The scope of this omnibus solicitation is very broad, spanning education, environment, food and nutrition, health, income security, and social services, which reflects the combined missions of NIH, CDC, FDA, and ACF. The listing of many CFDA numbers highlights the diversity of program areas that may support SBIR projects under this umbrella. These include, for example, applied public health research; FDA-related research; environmental health; oral health; injury prevention and control; human genome research; deafness and communication disorders; complementary and integrative health; sleep disorders; mental health research; occupational safety and health; alcohol and drug abuse research; minority health and health disparities; translational science; research infrastructure; nursing research; and a wide range of cancer, cardiovascular, lung, blood, arthritis/musculoskeletal/skin, diabetes/digestive/kidney, neurological, allergy/infectious disease, microbiology/infectious disease, child health and development, aging, and vision research areas. The inclusion of social services and welfare reform research CFDA numbers also signals that projects addressing human services systems, family and child well-being, and related evaluation or demonstration activities may be relevant where they fit the SBIR topic framework and agency priorities.

Eligibility is limited to small businesses. Foreign entities (non-US institutions) are not eligible to apply, and non-US components of US organizations are not eligible to apply. However, the announcement notes that "foreign components," as defined in the NIH Grants Policy Statement, may be allowed, which typically means certain discrete project elements may be performed outside the US under specific rules and justification, while the applicant organization remains an eligible US small business and the project remains compliant with SBIR requirements. There is no cost sharing or matching requirement, which is important for small companies because it reduces the need to bring outside capital solely to meet a match obligation.

From an administrative timeline standpoint, the opportunity was posted on June 4, 2015, with an original and current closing date of April 5, 2016, and an archive date of May 6, 2016. Those dates indicate this specific posting is historical and no longer open, but it represents a standard NIH/agency approach to parent SBIR solicitations: a central FOA that accepts proposals across participating institutes and centers, typically using standard submission cycles and requiring applicants to select the most appropriate participating component and topic alignment.

The administering agency listed is the National Institutes of Health, reflecting NIH's role in hosting and managing much of the SBIR grant infrastructure for participating components, even when projects align with CDC, FDA, or ACF missions. Applicants are directed to the full announcement on the NIH grants site (PA-15-269) for complete requirements, including the topic listings, application instructions, review considerations, and any institute- or center-specific guidance. For technical issues accessing the announcement, the contact provided is the NIH Office of Extramural Research (OER) Webmaster (FBOWebmaster@OD.NIH.GOV), which is a practical support contact rather than a scientific program contact.

Overall, this omnibus parent SBIR FOA is best understood as a wide doorway for US small businesses to compete for federal R and D grant support to move innovative, mission-relevant technologies and solutions toward commercialization, spanning biomedical research, public health, regulatory science, and human services-related innovation areas covered by NIH, CDC, FDA, and ACF.

Browse more: Small Business Grants, Small Business Loans

Browse more business programs for Business Consultants, Innovation Research Organizations, Business Innovation

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Environment Food and Nutrition Health Income Security and Social Services

Next opportunity: High Quality Human and Non Human Primate Genome Sequences (U24)

Previous opportunity: BLM New Mexico Sierra County Integrated Weed Management Program

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 15 269

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 15 269) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 15 269", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.